Oceania · News · The Australian
LTR Pharma confirms rapid SPONTAN absorption as US development advances
The report, prepared by an independent clinical research organisation, confirms the interim findings LTR Pharma (ASX:LTP) revealed in May and completes the pharmacokinetic dataset…
Read the full article on The Australian Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theaustralian.com.au)
